chr17-5130609-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001304284.2(USP6):c.80G>A(p.Arg27Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001304284.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
USP6 | NM_001304284.2 | c.80G>A | p.Arg27Gln | missense_variant | 11/38 | ENST00000574788.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
USP6 | ENST00000574788.6 | c.80G>A | p.Arg27Gln | missense_variant | 11/38 | 1 | NM_001304284.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000757 AC: 19AN: 250920Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135704
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461584Hom.: 0 Cov.: 31 AF XY: 0.0000316 AC XY: 23AN XY: 727112
GnomAD4 genome AF: 0.000296 AC: 45AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74438
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | The c.80G>A (p.R27Q) alteration is located in exon 3 (coding exon 2) of the USP6 gene. This alteration results from a G to A substitution at nucleotide position 80, causing the arginine (R) at amino acid position 27 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at